In an order dated March 31, 2012, Judge Paul Gardephe of the Southern District of New York granted J.P. Morgan Securities LLC’s motion to dismiss federal securities fraud claims brought on behalf of a putative class of purchasers of auction rate securities (ARS) over a nearly four-year period. The suit related to the widespread failures of auctions for ARS in February 2008 as a result of which many investors were unable to sell their securities at auction.
Litigation Partner Bryce Friedman will speak at HB Litigation Conference’s “Food, Drug and Medical Device Litigation Forum” on April 24, 2012 in Minneapolis, Minnesota. Mr. Friedman will speak on a panel entitled “Hypothetical Ethics Exercise: Preserving Privilege in a Food, Drug or Medical Device Case,” which will address preserving attorney client privilege in the context of insurance coverage & Model Rule 1.6, sharing information, and privilege analysis with multiple defendants and insureds ...
Simpson Thacher represented Vanguard Health Systems, Inc. (“Vanguard”) in connection with the private placement offering, including registration rights for investors, of $375.0 million aggregate principal amount of 7.750% Senior Notes due 2019 issued by its wholly-owned subsidiaries, Vanguard Health Holding Company II, LLC (“VHS Holdco II”) and Vanguard Holding Company II, Inc. (together with VHS Holdco II, the “Issuers”), conducted in reliance on Rule 144A and Regulation S. The notes were iss...